STEINERT MYOTONIC DYSTROPHY

Clinical trials for STEINERT MYOTONIC DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new STEINERT MYOTONIC DYSTROPHY trials appear

Sign up with your email to follow new studies for STEINERT MYOTONIC DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Four-Year trial tests potential new treatment for debilitating muscle disease

Disease control ENROLLING_BY_INVITATION

This study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…

Matched conditions: STEINERT MYOTONIC DYSTROPHY

Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

STEINERT MYOTONIC DYSTROPHY

Get alerted when new STEINERT MYOTONIC DYSTROPHY trials appear

Four-Year trial tests potential new treatment for debilitating muscle disease